The first Veracyte trade was made in Q2 2016.
Since then Chuck Royce bought shares two more times and sold shares on six occasions. The investor completely sold their stake between Q2 2019 and Q4 2020.
Avg closing price
Price range
Sold -40.2 Thousand shares
Q4 2020
Avg closing price
$46.34
Price range
$32.49
-
$61.88
Sold 56.0% shares (-51 Thousand shares)
Q2 2020
Avg closing price
$24.92
Price range
$19.49
-
$28.11
Sold 38.1% shares (-56 Thousand shares)
Q4 2019
Avg closing price
$25.89
Price range
$20.78
-
$29.99
Sold 14.5% shares (-25 Thousand shares)
Q3 2019
Avg closing price
$26.60
Price range
$23.87
-
$30.93
Sold 30.3% shares (-75 Thousand shares)
Q2 2019
Avg closing price
$24.98
Price range
$22.10
-
$28.56
Increased shares by 229.5% (+172 Thousand shares)
Q3 2018